Company profile: Amerilab Technologies
1.1 - Company Overview
Company description
- Provider of effervescent product manufacturing and development, producing effervescent tablets for dietary supplements, nutraceuticals, herbals and pharmaceuticals; effervescent and non-effervescent powders in sachets or sticks; packaging and pouching (tubed and foil wrapping, sachet/stick); R&D from concept to commercialization; and custom formulation, blending, tableting and packaging services.
Products and services
- Manufacturing Services: Amerilab Technologies' custom-engineered manufacturing services deliver custom formulation, blending, tableting, and packaging of effervescent products, including tubed or foil-wrapped tablets and sachet or stick-packed powders
- Effervescent Tablets: Custom-formulated tablets dissolve quickly to deliver dietary supplements, nutraceuticals, herbals, and pharmaceuticals, with rapid effervescence enhancing dispersibility and suitability for tubed or foil-wrapped packaging
- Research and Development: Prototype-driven services develop and prototype new effervescent products, assisting clients from concept to commercialization
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Amerilab Technologies
Nutra-Med Packaging
HQ: United States
Website
- Description: Provider of supply chain management and contract packaging for pharmaceutical and healthcare products, offering blister packaging (thermoforming, cold forming, barcode printing), high-speed bottling (glass vials/bottles, labeling, gummy vitamins, serialization/aggregation), secondary assembly and kitting, cartoning, serialization for bottles, blisters and cartons, and cold chain storage with 80 pallet locations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutra-Med Packaging company profile →
Javara
HQ: United States
Website
- Description: Provider of integrated clinical research services to healthcare organizations, delivering turnkey, practice-based clinical trial infrastructure to expand access to clinical trials and change the clinical research experience for providers and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Javara company profile →
Apicore
HQ: United States
Website
- Description: Provider of process R&D and active pharmaceutical ingredient (API) manufacturing services for the pharmaceutical industry worldwide, specializing in difficult-to-synthesize, high-value, and niche specialty APIs, serving customers in the generic medicine industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apicore company profile →
JSS Medical Research
HQ: Canada
Website
- Description: Provider of full-service clinical research organization (CRO) with strong academic affiliations, offering services internationally, including management of Phase I-III clinical trials; design and execution of late and post-approval studies; market access and HEOR (budget impact analysis, cost-effectiveness models); regulatory and clinical development consulting; biostatistics; and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full JSS Medical Research company profile →
BioClin Labs
HQ: Ireland
Website
- Description: Provider of internationally recognised expert analytical services and rapid reporting of data to support drug development and product release, leveraging breadth of scientific experience and knowledge across a wide range of techniques to develop optimal methods that run efficiently and meet regulatory.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioClin Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Amerilab Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Amerilab Technologies
2.2 - Growth funds investing in similar companies to Amerilab Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Amerilab Technologies
4.2 - Public trading comparable groups for Amerilab Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →